ATRA - Atara Biotherapeutics, Inc.

5.17
0.170   3.288%

Share volume: 3,201,173
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.17%

PREVIOUS CLOSE
CHG
CHG%
$5.00
0.17
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Report Date 05-09-2024 08-12-2024 11-12-2024 03-07-2025 05-15-2025 08-11-2025 11-12-2025
Total revenue 27.357 M 28.640 M 40.190 M 32.753 M 98.149 M 17.575 M 3.453 M
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 27.357 M 28.640 M 40.190 M 32.753 M 98.149 M 17.575 M 3.453 M
    4.69% 40.33% -18.50% 199.66% -82.09% -80.35%  
Operating expenses 56.619 M 42.244 M 54.345 M 38.161 M 38.908 M 13.824 M 6.912 M
Selling general and admin 11.113 M 8.912 M 10.421 M 9.440 M 11.475 M 6.514 M 3.987 M
Research and development 45.506 M 33.332 M 43.924 M 28.721 M 27.433 M 7.310 M 2.925 M
Total expenses 58.604 M 46.871 M 61.947 M 44.956 M 59.347 M 14.378 M 7.027 M
    -20.02% 32.16% -27.43% 32.01% -75.77% -51.13%  
Operating income -31.247 M -18.231 M -21.757 M -12.203 M 38.802 M 3.197 M -3.574 M
Ebit -31.179 M -18.237 M -21.202 M -12.292 M 38.791 M 3.219 M -3.570 M
Pretax income -31.728 M -19.049 M -21.926 M -12.712 M 38.010 M 2.390 M -4.275 M
    -39.96% 15.10% -42.02% -399.01% -93.71% -278.87%  
Income tax 24.000 K 0.000 -17.000 K -19.000 K 0.000 3.000 K 28.000 K
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -31.752 M -19.049 M -21.909 M -12.693 M 38.010 M 2.387 M -4.303 M
    40.01% -15.01% 42.06% 399.46% -93.72% -280.27%